These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19166659)

  • 1. Nonalcoholic fatty liver disease and cardiovascular risk.
    Misra VL; Khashab M; Chalasani N
    Curr Gastroenterol Rep; 2009 Feb; 11(1):50-5. PubMed ID: 19166659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population.
    Stepanova M; Younossi ZM
    Clin Gastroenterol Hepatol; 2012 Jun; 10(6):646-50. PubMed ID: 22245962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease.
    Corey KE; Chalasani N
    Clin Gastroenterol Hepatol; 2014 Jul; 12(7):1077-84; quiz e59-60. PubMed ID: 23962548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study.
    Dunn W; Xu R; Wingard DL; Rogers C; Angulo P; Younossi ZM; Schwimmer JB
    Am J Gastroenterol; 2008 Sep; 103(9):2263-71. PubMed ID: 18684196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty liver: a link to cardiovascular disease--its natural history, pathogenesis, and treatment.
    Monsour HP; Frenette CT; Wyne K
    Methodist Debakey Cardiovasc J; 2012; 8(3):21-5. PubMed ID: 23227282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interactions of nonalcoholic fatty liver disease and cardiovascular diseases.
    Perazzo H; Poynard T; Dufour JF
    Clin Liver Dis; 2014 Feb; 18(1):233-48. PubMed ID: 24274877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease and vascular risk.
    Bhatia LS; Curzen NP; Byrne CD
    Curr Opin Cardiol; 2012 Jul; 27(4):420-8. PubMed ID: 22596186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty liver, cardiometabolic disease and mortality.
    Bedogni G; Gastaldelli A; Foschi FG
    Curr Opin Lipidol; 2020 Feb; 31(1):27-31. PubMed ID: 31789677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease and the metabolic syndrome: clinical implications and treatment.
    Rahimi RS; Landaverde C
    Nutr Clin Pract; 2013 Feb; 28(1):40-51. PubMed ID: 23286927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease (NAFLD): a new risk factor for adverse cardiovascular events in dialysis patients.
    Mikolasevic I; Racki S; Zaputovic L; Lukenda V; Milic S; Orlic L
    Med Hypotheses; 2014 Feb; 82(2):205-8. PubMed ID: 24365277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspective: nonalcoholic fatty liver disease and cardiovascular risk.
    Nestel PJ; Mensink RP
    Curr Opin Lipidol; 2013 Feb; 24(1):1-3. PubMed ID: 23298957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease.
    Ong JP; Pitts A; Younossi ZM
    J Hepatol; 2008 Oct; 49(4):608-12. PubMed ID: 18682312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.
    Mikolasevic I; Milic S; Racki S; Zaputovic L; Stimac D; Radic M; Markic D; Orlic L
    Perit Dial Int; 2016; 36(4):427-32. PubMed ID: 26475841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease.
    Byrne CD; Targher G
    Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1155-61. PubMed ID: 24743428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.
    Villanova N; Moscatiello S; Ramilli S; Bugianesi E; Magalotti D; Vanni E; Zoli M; Marchesini G
    Hepatology; 2005 Aug; 42(2):473-80. PubMed ID: 15981216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps.
    Santos RD; Valenti L; Romeo S
    Atherosclerosis; 2019 Mar; 282():110-120. PubMed ID: 30731283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cardiovascular link to nonalcoholic fatty liver disease: a critical analysis.
    Pacana T; Fuchs M
    Clin Liver Dis; 2012 Aug; 16(3):599-613. PubMed ID: 22824483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrahepatic complications of nonalcoholic fatty liver disease.
    Armstrong MJ; Adams LA; Canbay A; Syn WK
    Hepatology; 2014 Mar; 59(3):1174-97. PubMed ID: 24002776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Review: Nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications.
    Targher G; Byrne CD
    J Clin Endocrinol Metab; 2013 Feb; 98(2):483-95. PubMed ID: 23293330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease and nonalcoholic fatty liver disease: does histologic severity matter?
    Domanski JP; Park SJ; Harrison SA
    J Clin Gastroenterol; 2012; 46(5):427-30. PubMed ID: 22469639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.